USP32 facilitates tumor development and is correlated with poor clinical outcomes in hepatocellular carcinoma patients and is modulated by the E2F7/miR-218-5p axis

Xin-yi Luo, Yi-quan Lu, Yi-fan Zhang, Nan Wang, Feng-jie Hao, Xiao-chun Fei, Yong-jun Chen, Jun-qing Wang

Open source

DOI
10.1016/j.lmd.2025.100102
Published
12
Container
LabMed Discovery
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.lmd.2025.100102,
  title = {USP32 facilitates tumor development and is correlated with poor clinical outcomes in hepatocellular carcinoma patients and is modulated by the E2F7/miR-218-5p axis},
  author = {Xin-yi Luo and Yi-quan Lu and Yi-fan Zhang and Nan Wang and Feng-jie Hao and Xiao-chun Fei and Yong-jun Chen and Jun-qing Wang},
  year = {2025},
  journal = {LabMed Discovery},
  doi = {10.1016/j.lmd.2025.100102},
  url = {https://doi.org/10.1016/j.lmd.2025.100102}
}

RIS

TY  - JOUR
TI  - USP32 facilitates tumor development and is correlated with poor clinical outcomes in hepatocellular carcinoma patients and is modulated by the E2F7/miR-218-5p axis
AU  - Xin-yi Luo
AU  - Yi-quan Lu
AU  - Yi-fan Zhang
AU  - Nan Wang
AU  - Feng-jie Hao
AU  - Xiao-chun Fei
AU  - Yong-jun Chen
AU  - Jun-qing Wang
PY  - 2025
JO  - LabMed Discovery
DO  - 10.1016/j.lmd.2025.100102
UR  - https://doi.org/10.1016/j.lmd.2025.100102
ER  - 

APA

Luo, X., Lu, Y., Zhang, Y., Wang, N., Hao, F., Fei, X., Chen, Y., & Wang, J. (2025). USP32 facilitates tumor development and is correlated with poor clinical outcomes in hepatocellular carcinoma patients and is modulated by the E2F7/miR-218-5p axis. LabMed Discovery. https://doi.org/10.1016/j.lmd.2025.100102

Source records